Roche Holding Ag Stock Beta
RHHBF Stock | USD 275.03 7.20 2.69% |
Roche Holding AG fundamentals help investors to digest information that contributes to Roche Holding's financial success or failures. It also enables traders to predict the movement of Roche OTC Stock. The fundamental analysis module provides a way to measure Roche Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roche Holding otc stock.
Roche |
Roche Holding AG OTC Stock Beta Analysis
Roche Holding's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Roche Holding Beta | 0.19 |
Most of Roche Holding's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roche Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Roche Holding AG has a Beta of 0.1878. This is 78.16% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The beta for all United States stocks is notably lower than that of the firm.
Roche Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roche Holding's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Roche Holding could also be used in its relative valuation, which is a method of valuing Roche Holding by comparing valuation metrics of similar companies.Roche Holding is currently under evaluation in beta category among related companies.
As returns on the market increase, Roche Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Roche Holding is expected to be smaller as well.
Roche Fundamentals
Return On Equity | 0.45 | |||
Return On Asset | 0.15 | |||
Profit Margin | 0.19 % | |||
Operating Margin | 0.32 % | |||
Current Valuation | 287.91 B | |||
Shares Outstanding | 106.69 M | |||
Shares Owned By Insiders | 75.31 % | |||
Shares Owned By Institutions | 8.56 % | |||
Price To Earning | 21.63 X | |||
Price To Book | 11.61 X | |||
Price To Sales | 4.11 X | |||
Revenue | 62.8 B | |||
Gross Profit | 47.83 B | |||
EBITDA | 22.26 B | |||
Net Income | 13.93 B | |||
Cash And Equivalents | 6.81 B | |||
Cash Per Share | 8.50 X | |||
Total Debt | 16.08 B | |||
Debt To Equity | 1.00 % | |||
Current Ratio | 1.11 X | |||
Book Value Per Share | 35.03 X | |||
Cash Flow From Operations | 20.98 B | |||
Earnings Per Share | 19.18 X | |||
Price To Earnings To Growth | 4.18 X | |||
Target Price | 423.65 | |||
Number Of Employees | 103.61 K | |||
Beta | 0.19 | |||
Market Capitalization | 246.23 B | |||
Total Asset | 92.32 B | |||
Retained Earnings | 25.51 B | |||
Working Capital | 2.16 B | |||
Current Asset | 26.61 B | |||
Current Liabilities | 24.46 B | |||
Z Score | 9.0 | |||
Annual Yield | 0.03 % | |||
Five Year Return | 3.23 % | |||
Net Asset | 92.32 B | |||
Last Dividend Paid | 9.5 |
About Roche Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roche Holding AG. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Roche Holding AG information on this page should be used as a complementary analysis to other Roche Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Roche OTC Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |